task,metric,N,TxGemma-27B (repro),TxGravity-release,margin,basis,verdict
ames,AUROC,1457,0.8300,0.8410,+1.1,%p,TIE
bbb_martins,AUROC,406,0.8970,0.9190,+2.2,%p,TIE
bindingdb_ic50,Spearman,35725,0.6430,0.7660,+12.3,%p,WIN
bindingdb_kd,PCC,1630,0.5960,0.5220,-7.4,%p,LOSS
bindingdb_ki,PCC,11857,-0.1120,0.7500,+86.2,%p,WIN
bindingdb_patent,PCC,49028,0.5140,0.5410,+2.7,%p,TIE
bioavailability_ma,AUROC,128,0.6970,0.7490,+5.2,%p,WIN
buchwald_hartwig,PCC,791,0.8550,0.8920,+3.7,%p,WIN
butkiewicz,AUROC,401997,0.8620,0.7540,-10.8,%p,LOSS
caco2_wang,MAE,182,0.4660,0.4160,+10.7,%rel,WIN
carcinogens_lagunin,Accuracy,56,0.8930,0.8750,-1.8,%p,TIE
clearance_hepatocyte_az,Spearman,243,0.2910,0.3240,+3.3,%p,WIN
clearance_microsome_az,Spearman,221,0.4870,0.5000,+1.3,%p,TIE
clintox,AUROC,297,0.7560,0.7610,+0.5,%p,TIE
cyp1a2_veith,AUPRC,2517,0.9350,0.9310,-0.4,%p,TIE
cyp2c19_veith,AUROC,2534,0.8910,0.8940,+0.3,%p,TIE
cyp2c9_substrate_carbonmangels,AUPRC,135,0.4730,0.3460,-12.7,%p,LOSS
cyp2c9_veith,AUPRC,2419,0.7820,0.7920,+1.0,%p,TIE
cyp2d6_substrate_carbonmangels,AUPRC,135,0.7380,0.7080,-3.0,%p,LOSS
cyp2d6_veith,AUPRC,2626,0.6620,0.6840,+2.2,%p,TIE
cyp3a4_substrate_carbonmangels,AUROC,135,0.6950,0.6410,-5.4,%p,LOSS
cyp3a4_veith,AUPRC,2467,0.8410,0.8610,+2.0,%p,TIE
davis,MSE,1064,0.6430,0.7600,-18.2,%rel,LOSS
dili,AUROC,96,0.8890,0.8930,+0.4,%p,TIE
disgenet,MAE,10495,-,-,-,-,EXCL
drugcomb_bliss,MAE,59708,3.9280,3.7370,+4.9,%rel,WIN
drugcomb_css,MAE,59708,9.4180,7.8380,+16.8,%rel,WIN
drugcomb_hsa,MAE,59708,3.7880,3.5840,+5.4,%rel,WIN
drugcomb_loewe,MAE,59708,7.6720,6.4130,+16.4,%rel,WIN
drugcomb_zip,MAE,59708,3.4100,3.0610,+10.2,%rel,WIN
gdsc1,PCC,35462,-,-,-,-,EXCL
gdsc2,PCC,18541,-,-,-,-,EXCL
half_life_obach,Spearman,135,0.2890,0.3600,+7.1,%p,WIN
herg,AUROC,132,0.9000,0.8930,-0.7,%p,TIE
herg_central,AUROC,61379,0.8830,0.8760,-0.7,%p,TIE
herg_karim,Accuracy,2690,0.8000,0.7920,-0.8,%p,TIE
hia_hou,AUROC,117,0.9860,0.9860,+0.0,%p,TIE
hiv,AUROC,8227,0.7930,0.7640,-2.9,%p,TIE
huri,AUPRC,4204,0.7920,0.8080,+1.6,%p,TIE
kiba,MSE,4537,0.4600,0.6370,-38.5,%rel,LOSS
ld50_zhu,MAE,1478,0.7760,0.6510,+16.1,%rel,WIN
leenay,Spearman,1520,0.2260,0.1510,-7.5,%p,LOSS
lipophilicity_astrazeneca,MAE,840,0.5950,0.5700,+4.2,%rel,WIN
mhc1_iedb_imgt_nielsen,AUROC,37197,0.9680,0.9200,-4.8,%p,LOSS
mhc2_iedb_jensen,AUROC,26856,0.8500,0.8680,+1.8,%p,TIE
mirtarbase,Accuracy,160033,0.8040,0.5550,-24.9,%p,LOSS
oncopolypharmacology,PCC,4647,0.5690,0.5050,-6.4,%p,LOSS
pampa_ncats,AUROC,408,0.7080,0.6630,-4.5,%p,LOSS
pgp_broccatelli,AUROC,245,0.9320,0.9380,+0.6,%p,TIE
phase1,AUROC,561,-,-,-,-,EXCL
phase2,AUROC,1279,-,-,-,-,EXCL
phase3,AUROC,1200,-,-,-,-,EXCL
ppbr_az,MAE,559,9.4180,8.2900,+12.0,%rel,WIN
protein_sabdab,MAE,99,2.3320,0.9690,+58.4,%rel,WIN
sabdab_chen,AUPRC,482,0.7080,0.6580,-5.0,%p,LOSS
sarscov2_3clpro_diamond,AUROC,176,0.7250,0.7470,+2.2,%p,TIE
sarscov2_vitro_touret,AUROC,298,0.5300,0.4580,-7.2,%p,LOSS
skin_reaction,AUROC,82,0.6370,0.6510,+1.4,%p,TIE
solubility_aqsoldb,MAE,1997,0.8050,0.8550,-6.2,%rel,LOSS
tap,MAE,240,4.7850,5.4400,-13.7,%rel,LOSS
tox21,AUROC,15600,0.8430,0.8230,-2.0,%p,TIE
toxcast,AUROC,307282,0.9050,0.8970,-0.8,%p,TIE
uspto,Accuracy,221648,0.0880,0.0000,-8.8,%p,LOSS
uspto_yields,PCC,170728,0.1860,-0.0571,-24.3,%p,LOSS
vdss_lombardo,Spearman,226,0.5660,0.5820,+1.6,%p,TIE
weber,AUROC,9417,0.7390,0.7180,-2.1,%p,TIE